Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 22
Filtrer
1.
Res Rep Trop Med ; 12: 235-245, 2021.
Article de Anglais | MEDLINE | ID: mdl-34737667

RÉSUMÉ

We present a historical review of two neglected tropical diseases (NTD), namely, onchocerciasis and trachoma, both which were successfully eliminated in Mexico. In addition, we present a cost-effectiveness assessment (CEA) demonstrating that these were worthwhile health interventions. Historically, an estimate of $310.68 and $38.92 per person were spent during the period of time the onchocerciasis and trachoma elimination programs operated, respectively.

2.
Am J Trop Med Hyg ; 103(4): 1569-1571, 2020 10.
Article de Anglais | MEDLINE | ID: mdl-32840200

RÉSUMÉ

Onchocerciasis is a blinding disease caused by the filarial parasite Onchocerca volvulus, with a worldwide distribution. Onchocerciasis has been targeted for regional elimination based on annual and semiannual mass drug administration (MDA) with ivermectin in endemic communities over several years. This strategy in Ecuador led to the interruption of transmission and suspension of ivermectin MDA in 2009 with certification of elimination in 2014. In the present study, we analyzed sera collected in 2018 from 123 children aged 5-9 years from formerly hyperendemic communities in the Esmeraldas focus, Ecuador, for the presence of antibodies to Ov16 antigen. All samples were negative, indicating no evidence of transmission since MDA was stopped. Ov16-based serology offers an economic and practical alternative for measuring vector infectivity for post-certification surveillance in formerly endemic countries where expertise and capacity to reliably measure fly infectivity rates are costly to maintain.


Sujet(s)
Onchocerca volvulus/immunologie , Onchocercose/épidémiologie , Animaux , Enfant , Enfant d'âge préscolaire , Éradication de maladie , Équateur/épidémiologie , Maladies endémiques , Surveillance épidémiologique , Femelle , Humains , Mâle , Onchocerca volvulus/isolement et purification , Onchocercose/parasitologie , Onchocercose/prévention et contrôle
3.
PLoS Negl Trop Dis ; 14(1): e0008008, 2020 01.
Article de Anglais | MEDLINE | ID: mdl-31999704

RÉSUMÉ

BACKGROUND: All formerly endemic communities of the Southern Chiapas focus of onchocerciasis in Mexico were treated with ivermectin until parasite transmission was eliminated by 2015. Transmission of onchocerciasis did not resume during a period of three years (2012-2014) following the final distribution of ivermectin in 2011; it was thus concluded that transmission remained undetectable without intervention. WHO thus declared the elimination of transmission of onchocerciasis from Mexico in 2015. METHODOLOGY/PRINCIPAL FINDINGS: From 2016 to the present, post-elimination surveillance (PES) based on examination for suspected onchocercomas was performed in the former Southern Chiapas focus. Each year, over 60% of the total population (range = 85,347-104,106 individuals) of the formerly endemic communities were examined for onchocercomas. Thirty-four individuals were found harboring suspected onchocercomas in the PES surveys conducted from 2016-2019. Of these, one female of 7 years of age who had immigrated from a formerly endemic focus, harbored an infertile (sterile) female in the suspected onchocercoma; all others were negative. Skin biopsy assessments were performed from March through May 2017 in three communities where the female resided. None of the 83 individuals of the three communities examined by skin biopsy were mf positive. Similarly, none of the biopsies from the individuals were found to contain parasite DNA when tested by polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA). CONCLUSIONS/SIGNIFICANCE: These provide support to the conclusion that onchocerciasis has been eliminated from Mexico.


Sujet(s)
Ivermectine/usage thérapeutique , Onchocerca volvulus , Onchocercose/traitement médicamenteux , Onchocercose/épidémiologie , Surveillance de la population , Adolescent , Adulte , Sujet âgé , Animaux , Enfant , Enfant d'âge préscolaire , ADN des helminthes/génétique , Éradication de maladie , Femelle , Humains , Nourrisson , Ivermectine/administration et posologie , Mâle , Administration massive de médicament , Mexique/épidémiologie , Adulte d'âge moyen , Réaction de polymérisation en chaîne/méthodes , Peau/parasitologie , Jeune adulte
4.
PLoS Negl Trop Dis ; 11(7): e0005686, 2017 Jul.
Article de Anglais | MEDLINE | ID: mdl-28686665

RÉSUMÉ

BACKGROUND: The Esperanza Window Trap (EWT) baited with CO2 and human sweat compounds is attractive to Simulium ochraceum s.l., the primary vector of Onchocerca volvulus in the historically largest endemic foci in México and Guatemala. METHODOLOGY/PRINCIPAL FINDINGS: The ability of the EWT to locally reduce numbers of questing S. ochraceum s.l. was evaluated in two formerly onchocerciasis endemic communities in Southern México. At each community, two EWTs were placed in or near a school or household and flies were collected sequentially for a total of 10 days. Black fly collections were then carried out for an additional 10 days in the absence of the EWTs. Flies were also collected outside the dwellings to control for variations in the local fly populations. When the EWTs were present, there was a significant reduction in the human biting rate at both the household and school locations at collection sites, with a greater effect observed in the schools. CONCLUSIONS/SIGNIFICANCE: These results indicate that the EWTs not only have potential as a black fly monitoring tool but may be used for reducing personal exposure to fly bites in Mesoamerica.


Sujet(s)
Morsures et piqûres d'insectes/épidémiologie , Lutte contre les insectes/méthodes , Onchocercose/prévention et contrôle , Simuliidae , Animaux , Entomologie , Interactions hôte-parasite , Humains , Vecteurs insectes/parasitologie , Mexique , Onchocerca volvulus , Onchocercose/transmission , Analyse de régression , Simuliidae/parasitologie
5.
Nat Microbiol ; 2: 16207, 2016 Nov 21.
Article de Anglais | MEDLINE | ID: mdl-27869792

RÉSUMÉ

Ongoing elimination efforts have altered the global distribution of Onchocerca volvulus, the agent of river blindness, and further population restructuring is expected as efforts continue. Therefore, a better understanding of population genetic processes and their effect on biogeography is needed to support elimination goals. We describe O. volvulus genome variation in 27 isolates from the early 1990s (before widespread mass treatment) from four distinct locales: Ecuador, Uganda, the West African forest and the West African savanna. We observed genetic substructuring between Ecuador and West Africa and between the West African forest and savanna bioclimes, with evidence of unidirectional gene flow from savanna to forest strains. We identified forest:savanna-discriminatory genomic regions and report a set of ancestry informative loci that can be used to differentiate between forest, savanna and admixed isolates, which has not previously been possible. We observed mito-nuclear discordance possibly stemming from incomplete lineage sorting. The catalogue of the nuclear, mitochondrial and endosymbiont DNA variants generated in this study will support future basic and translational onchocerciasis research, with particular relevance for ongoing control programmes, and boost efforts to characterize drug, vaccine and diagnostic targets.


Sujet(s)
Variation génétique , Onchocerca volvulus/classification , Onchocerca volvulus/génétique , Wolbachia/classification , Wolbachia/génétique , Afrique de l'Ouest , Animaux , Équateur , Flux des gènes , Génotype , Onchocerca volvulus/isolement et purification , Onchocerca volvulus/microbiologie , Phylogéographie , Ouganda
6.
Parasit Vectors ; 9: 40, 2016 Jan 27.
Article de Anglais | MEDLINE | ID: mdl-26813296

RÉSUMÉ

BACKGROUND: The World Health Organization (WHO) has set goals for onchocerciasis elimination in Latin America by 2015. Most of the six previously endemic countries are attaining this goal by implementing twice a year (and in some foci, quarterly) mass ivermectin (Mectizan®) distribution. Elimination of transmission has been verified in Colombia, Ecuador and Mexico. Challenges remain in the Amazonian focus straddling Venezuela and Brazil, where the disease affects the hard-to-reach Yanomami indigenous population. We provide evidence of suppression of Onchocerca volvulus transmission by Simulium guianense s.l. in 16 previously hyperendemic Yanomami communities in southern Venezuela after 15 years of 6-monthly and 5 years of 3-monthly mass ivermectin treatment. METHODS: Baseline and monitoring and evaluation parasitological, ophthalmological, entomological and serological surveys were conducted in selected sentinel and extra-sentinel communities of the focus throughout the implementation of the programme. RESULTS: From 2010 to 2012-2015, clinico-parasitological surveys indicate a substantial decrease in skin microfilarial prevalence and intensity of infection; accompanied by no evidence (or very low prevalence and intensity) of ocular microfilariae in the examined population. Of a total of 51,341 S. guianense flies tested by PCR none had L3 infection (heads only). Prevalence of infective flies and seasonal transmission potentials in 2012-2013 were, respectively, under 1% and 20 L3/person/transmission season. Serology in children aged 1-10 years demonstrated that although 26 out of 396 (7%) individuals still had Ov-16 antibodies, only 4/218 (2%) seropositives were aged 1-5 years. CONCLUSIONS: We report evidence of recent transmission and morbidity suppression in some communities of the focus representing 75% of the Yanomami population and 70% of all known communities. We conclude that onchocerciasis transmission could be feasibly interrupted in the Venezuelan Amazonian focus.


Sujet(s)
Vecteurs insectes/parasitologie , Insecticides/usage thérapeutique , Ivermectine/usage thérapeutique , Onchocerca volvulus/physiologie , Onchocercose/transmission , Simuliidae/parasitologie , Animaux , Enfant d'âge préscolaire , Femelle , Géographie , Humains , Nourrisson , Mâle , Microfilaria , Onchocerca volvulus/génétique , Onchocercose/épidémiologie , Onchocercose/parasitologie , Onchocercose/prévention et contrôle , Prévalence , Saisons , Venezuela/épidémiologie
7.
Am J Trop Med Hyg ; 93(6): 1295-304, 2015 Dec.
Article de Anglais | MEDLINE | ID: mdl-26503275

RÉSUMÉ

We report the elimination of Onchocerca volvulus transmission from the Central Endemic Zone (CEZ) of onchocerciasis in Guatemala, the largest focus of this disease in the Americas and the first to be discovered in this hemisphere by Rodolfo Robles Valverde in 1915. Mass drug administration (MDA) with ivermectin was launched in 1988, with semiannual MDA coverage reaching at least 85% of the eligible population in > 95% of treatment rounds during the 12-year period, 2000-2011. Serial parasitological testing to monitor MDA impact in sentinel villages showed a decrease in microfilaria skin prevalence from 70% to 0%, and polymerase chain reaction (PCR)-based entomological assessments of the principal vector Simulium ochraceum s.l. showed transmission interruption by 2007. These assessments, together with a 2010 serological survey in children 9-69 months of age that showed Ov16 IgG4 antibody prevalence to be < 0.1%, meeting World Health Organization (WHO) guidelines for stopping MDA, and treatment was halted after 2011. After 3 years an entomological assessment showed no evidence of vector infection or recrudescence of transmission. In 2015, 100 years after the discovery of its presence, the Ministry of Health of Guatemala declared onchocerciasis transmission as having been eliminated from the CEZ.


Sujet(s)
Éradication de maladie , Onchocerca volvulus , Onchocercose/prévention et contrôle , Animaux , Enfant d'âge préscolaire , Oeil/parasitologie , Femelle , Filaricides/usage thérapeutique , Guatemala/épidémiologie , Humains , Lutte contre les insectes , Vecteurs insectes/parasitologie , Ivermectine/usage thérapeutique , Mâle , Onchocercose/traitement médicamenteux , Onchocercose/épidémiologie , Onchocercose/transmission , Simuliidae/parasitologie , Peau/parasitologie
8.
PLoS Negl Trop Dis ; 9(7): e0003922, 2015.
Article de Anglais | MEDLINE | ID: mdl-26161558

RÉSUMÉ

BACKGROUND: Mexico is one of the six countries formerly endemic for onchocerciasis in Latin America. Transmission has been interrupted in the three endemic foci of that country and mass drug distribution has ceased. Three years after mass drug distribution ended, post-treatment surveillance (PTS) surveys were undertaken which employed entomological indicators to check for transmission recrudescence. METHODOLOGY/PRINCIPAL FINDINGS: In-depth entomologic assessments were performed in 18 communities in the three endemic foci of Mexico. None of the 108,212 Simulium ochraceum s.l. collected from the three foci were found to contain parasite DNA when tested by polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA), resulting in a maximum upper bound of the 95% confidence interval (95%-ULCI) of the infective rate in the vectors of 0.035/2,000 flies examined. This is an order of magnitude below the threshold of a 95%-ULCI of less than one infective fly per 2,000 flies tested, the current entomological criterion for interruption of transmission developed by the international community. The point estimate of seasonal transmission potential (STP) was zero, and the upper bound of the 95% confidence interval for the STP ranged from 1.2 to 1.7 L3/person/season in the different foci. This value is below all previous estimates for the minimum transmission potential required to maintain the parasite population. CONCLUSIONS/SIGNIFICANCE: The results from the in-depth entomological post treatment surveillance surveys strongly suggest that transmission has not resumed in the three foci of Mexico during the three years since the last distribution of ivermectin occurred; it was concluded that transmission remains undetectable without intervention, and Onchocerca volvulus has been eliminated from Mexico.


Sujet(s)
Onchocercose/prévention et contrôle , Simuliidae/parasitologie , Animaux , Anthelminthiques/administration et posologie , Femelle , Humains , Vecteurs insectes/parasitologie , Vecteurs insectes/physiologie , Ivermectine/administration et posologie , Mâle , Mexique/épidémiologie , Onchocerca volvulus/génétique , Onchocerca volvulus/isolement et purification , Onchocerca volvulus/physiologie , Onchocercose/traitement médicamenteux , Onchocercose/épidémiologie , Onchocercose/transmission , Simuliidae/physiologie
9.
PLoS Negl Trop Dis ; 8(10): e3249, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-25340517

RÉSUMÉ

BACKGROUND: Collection of the black fly vectors of onchocerciasis worldwide relies upon human landing collections. Recent studies have suggested that the Esperanza Window Trap baited with a human scent lure and CO2 had the potential to replace human hosts for the collection of Simulium ochraceum sensu lato in Southern Chiapas focus, Mexico. The feasibility of utilizing these traps in a community-based approach for the collection of S. ochraceum s.l. was evaluated. METHODOLOGY/PRINCIPAL FINDINGS: Local residents of a formerly endemic extra-sentinel community for onchocerciasis were trained to carry out collections using the traps. The residents operated the traps over a 60-day period and conducted parallel landing collections, resulting in a total of 28,397 vector black flies collected. None of the flies collected were found to contain parasite DNA when tested by a polymerase chain reaction assay targeting a parasite specific sequence, resulting in a point estimate of infection in the vectors of zero, with an upper bound of the 95% confidence interval 0.13 per 2,000. This meets the accepted criterion for demonstrating an interruption of parasite transmission. CONCLUSIONS/SIGNIFICANCE: These data demonstrate that Esperanza Window Traps may be effectively operated by minimally trained residents of formerly endemic communities, resulting in the collection of sufficient numbers of flies to verify transmission interruption of onchocerciasis. The traps represent a viable alternative to using humans as hosts for the collection of vector flies as part of the verification of onchocerciasis elimination.


Sujet(s)
Lutte contre les insectes/méthodes , Onchocercose/prévention et contrôle , Simuliidae , Animaux , Humains , Vecteurs insectes , Mexique , Onchocercose/transmission
10.
PLoS Negl Trop Dis ; 7(3): e2133, 2013.
Article de Anglais | MEDLINE | ID: mdl-23556018

RÉSUMÉ

BACKGROUND: The Southern Chiapas focus of onchocerciasis in Southern Mexico represents one of the major onchocerciasis foci in Latin America. All 559 endemic communities of this focus have undergone semi-annual mass treatment with ivermectin since 1998. In 50 communities of this focus, ivermectin frequency shifted from twice to four times a year in 2003; an additional 113 communities were added to the quarterly treatment regimen in 2009 to achieve a rapid suppression of transmission. METHODOLOGY/PRINCIPAL FINDINGS: In-depth epidemiologic and entomologic assessments were performed in six sentinel communities (which had undergone 2 rounds of ivermectin treatment per year) and three extra-sentinel communities (which had undergone 4 rounds of ivermectin treatment per year). None of the 67,924 Simulium ochraceum s.l. collected from this focus during the dry season of 2011 were found to contain parasite DNA when tested by polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA), resulting in an upper bound of the 95% confidence interval (95%-ULCI) of the infective rate in the vectors of 0.06/2,000 flies examined. Serological assays testing for Onchocerca volvulus exposure conducted on 4,230 children 5 years of age and under (of a total population of 10,280 in this age group) revealed that 2/4,230 individuals were exposed to O. volvulus (0.05%; one sided 95% confidence interval = 0.08%). CONCLUSIONS/SIGNIFICANCE: The in-depth epidemiological and entomological findings from the Southern Chiapas focus meet the criteria for interruption of transmission developed by the international community.


Sujet(s)
Anthelminthiques/administration et posologie , Ivermectine/administration et posologie , Onchocerca volvulus/isolement et purification , Onchocercose/épidémiologie , Onchocercose/prévention et contrôle , Animaux , Enfant , Enfant d'âge préscolaire , ADN des helminthes/isolement et purification , Test ELISA , Femelle , Humains , Nourrisson , Mâle , Mexique/épidémiologie , Onchocerca volvulus/génétique , Onchocercose/traitement médicamenteux , Onchocercose/parasitologie , Réaction de polymérisation en chaîne , Simuliidae/parasitologie
11.
J Med Entomol ; 49(4): 917-21, 2012 Jul.
Article de Anglais | MEDLINE | ID: mdl-22897052

RÉSUMÉ

The distribution of Aedes (Stegomyia) aegypti (L.), the main vector of dengue viruses (DENV) worldwide, overlaps with Aedes (Gymnometopa) mediovittatus (Coquillett), the Caribbean treehole mosquito, in urban, suburban, and rural areas. Ae. mediovittatus is a competent vector of DENV with high rates of vertical DENV transmission in the laboratory. This study determined whether Ae. mediovittatus feeds on humans and compared its feeding patterns with co-occurring Ae. aegypti in two rural communities of Puerto Rico. Adult mosquitoes were captured for three consecutive days every week from July 2009 to May 2010 using BG-Sentinel traps with skin lures that were placed in the front yard of houses in both communities. Three methods were used to identify the 756 bloodmeals obtained in this study: a multiplex polymerase chain reaction (PCR) for humans and dogs targeting cytochrome b; a PCR targeting the 16S rRNA; and a nested PCR targeting cytochrome b. Ae. mediovittatus fed mostly on humans (45-52%) and dogs (28-32%) but also on cats, cows, horses, rats, pigs, goats, sheep, and chickens. Ae. aegypti fed mostly on humans (76-79%) and dogs (18-21%) but also on cats, horses, and chickens. Our results indicate that Ae. mediovittatus may have a relatively high rate of vector-human contact, which might facilitate virus transmission or harborage in rural areas of Puerto Rico.


Sujet(s)
Aedes/physiologie , Interactions hôte-parasite , Vecteurs insectes/physiologie , Animaux , Chiens , Comportement alimentaire , Femelle , Humains , Porto Rico
12.
Am J Trop Med Hyg ; 83(1): 21-7, 2010 Jul.
Article de Anglais | MEDLINE | ID: mdl-20595472

RÉSUMÉ

All endemic communities of the Oaxaca focus of onchocerciasis in southern Mexico have been treated annually or semi-annually with ivermectin since 1994. In-depth epidemiologic assessments were performed in communities during 2007 and 2008. None of the 52,632 Simulium ochraceum s.l. collected in four sentinel communities was found to contain parasite DNA when tested by polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA), resulting in an upper bound of the infection rate in the vectors of 0.07/2,000. The prevalence of microfilariae (mf) in the cornea and/or anterior chamber of the eye was also zero (0 of 1,039 residents examined; 95%-UL = 0.35%). Similarly, all 1,164 individuals examined by skin biopsy were mf negative (95%-UL = 0.31%), and sera collected from 3,569 children from 25 communities did not harbor Ov16 IgG4-antibodies (95%-UL = 0.09%). These meet the criteria for absence of morbidity and parasite transmission in the Oaxaca focus. As a result mass treatments with ivermectin were halted in 2009.


Sujet(s)
Anthelminthiques/pharmacologie , Ivermectine/pharmacologie , Onchocerca volvulus/effets des médicaments et des substances chimiques , Onchocercose/transmission , Animaux , Transmission de maladie infectieuse , Humains , Mexique , Onchocerca volvulus/immunologie , Onchocercose/épidémiologie , Onchocercose/immunologie , Onchocercose/parasitologie
13.
Am J Trop Med Hyg ; 83(1): 15-20, 2010 Jul.
Article de Anglais | MEDLINE | ID: mdl-20595471

RÉSUMÉ

The northern Chiapas onchocerciasis focus has undergone 11 years of ivermectin mass treatment. No evidence of microfilariae in the cornea and/or anterior chamber of the eye or in skin snips was seen in residents examined in 2006 in two sentinel communities (upper limit of the 95% confidence interval [UL 95% CI] = 0.5% and 0.3%, respectively). In children 10 and under, 0 of 305 were found to harbor antibodies to Ov16, a marker of parasite exposure; 0 of 4,400 Simulium ochraceum s.l. collected in 2005 contained parasite DNA, giving an UL 95% CI for the infective rate of 0.9/2,000, and an UL 95% CI of the seasonal transmission potential of 1.2 L3/person. These data, assumed to be representative of the focus as a whole, suggest that there is no ongoing transmission of Onchocerca volvulus in the northern Chiapas focus. Community-wide treatments with ivermectin were halted in 2008, and a post-treatment surveillance phase was initiated.


Sujet(s)
Transmission de maladie infectieuse/prévention et contrôle , Onchocerca volvulus/effets des médicaments et des substances chimiques , Onchocercose/transmission , Animaux , Anthelminthiques/usage thérapeutique , Enfant , Enfant d'âge préscolaire , Humains , Ivermectine/usage thérapeutique , Mexique/épidémiologie , Onchocerca volvulus/immunologie , Onchocercose/immunologie , Onchocercose/parasitologie
14.
Vector Borne Zoonotic Dis ; 9(5): 555-60, 2009 Oct.
Article de Anglais | MEDLINE | ID: mdl-19281433

RÉSUMÉ

Prior to 2006, West Nile virus (WNV) had not been definitively detected in Chiapas, the southernmost state of Mexico, although it circulates elsewhere in Mexico and Central America. We collected over 30,000 mosquitoes and blood-sampled 351 domestic animals in Chiapas in search for evidence of current or recent transmission of WNV. Two mosquito pools tested positive for WNV RNA and 17 domestic animals tested positive for specific WNV-neutralizing antibodies, including young animals (<1 year old) in four of five sampled locations. The two WNV-positive mosquito pools were collected on the Pacific coastal plain of Chiapas in June, 2006, and included a pool of Culex nigripalpus, a suspected vector of WNV, and a pool of Cx. interrogator. The sequence of a 537-nucleotide portion of a cDNA amplicon derived from the WNV NS5 gene from the Cx. interrogator pool contained a single silent nucleotide substitution when compared to WNV strain NY99.


Sujet(s)
Maladies de l'animal/épidémiologie , Animaux domestiques/sang , Culicidae/virologie , Fièvre à virus West Nile/médecine vétérinaire , Virus du Nil occidental/isolement et purification , Maladies de l'animal/sang , Maladies de l'animal/virologie , Animaux , Anticorps antiviraux , Bovins , Femelle , Equus caballus , Mexique/épidémiologie , Volaille , Suidae , Fièvre à virus West Nile/sang , Fièvre à virus West Nile/épidémiologie
15.
Am J Trop Med Hyg ; 79(2): 239-44, 2008 Aug.
Article de Anglais | MEDLINE | ID: mdl-18689630

RÉSUMÉ

The impact of quarterly Mectizan (ivermectin) treatments on transmission, microfiladermia, and ocular lesions was evaluated in two formerly hyperendemic communities (Las Golondrinas and Las Nubes II) located in the main endemic focus for onchocerciasis in Southern Chiapas, Mexico. The data suggest that Onchocerca volvulus transmission has been suppressed after elimination of microfiladermia in these two communities. Increasing the frequency of Mectizan treatment to four times per year appears to have resulted in the rapid suppression of transmission in communities with residual transmission.


Sujet(s)
Filaricides/usage thérapeutique , Ivermectine/usage thérapeutique , Onchocerca volvulus/effets des médicaments et des substances chimiques , Onchocercose/prévention et contrôle , Animaux , Calendrier d'administration des médicaments , Filaricides/administration et posologie , Humains , Ivermectine/administration et posologie , Mexique/épidémiologie , Onchocercose/épidémiologie , Onchocercose/transmission , Peau/parasitologie
16.
Am J Trop Med Hyg ; 78(1): 147-52, 2008 Jan.
Article de Anglais | MEDLINE | ID: mdl-18187798

RÉSUMÉ

Entomologic and serologic surveys were performed in four sentinel communities in the Oaxaca focus in southern Mexico to assess the level of transmission and exposure incidence to Onchocerca volvulus. All communities have been receiving ivermectin mass treatment twice per year since 1997. In one community, parasite DNA was detected by polymerase chain reaction-enzyme-linked immunosorbent assay in 2004 in one pool of 50 vector heads of 170 such pools (8,500 flies) examined, which indicated an estimated transmission potential of 6.7 third-stage larvae/person/year. No evidence for transmission was found in the three other communities in 13,650 flies examined. All persons in a cohort consisting of 117 children in the four communities remained serologically negative for antibodies recognizing a cocktail of recombinant antigens over a four-year period from 2001 to 2004, which indicated an exposure incidence of 0%. Taken together, these data suggest that transmission has been suppressed in the four communities.


Sujet(s)
Onchocerca volvulus/isolement et purification , Onchocercose/épidémiologie , Onchocercose/prévention et contrôle , Animaux , Antigènes d'helminthe/analyse , ADN des helminthes/analyse , Test ELISA , Filaricides/usage thérapeutique , Humains , Incidence , Vecteurs insectes/parasitologie , Ivermectine/usage thérapeutique , Mexique/épidémiologie , Onchocerca volvulus/génétique , Onchocerca volvulus/immunologie , Onchocercose/étiologie , Onchocercose/transmission , Réaction de polymérisation en chaîne , Simuliidae/parasitologie
17.
Am J Trop Med Hyg ; 77(2): 334-41, 2007 Aug.
Article de Anglais | MEDLINE | ID: mdl-17690408

RÉSUMÉ

To eliminate transmission of Onchocerca volvulus, semiannual mass treatment with ivermectin (Mectizan; donated by Merck & Co) has been underway in Guatemala since 2000. We applied the 2001 World Health Organization (WHO) elimination criteria in the Santa Rosa focus of onchocerciasis transmission in Guatemala (10,923 persons at risk). No evidence of parasite DNA was found in 2,221 Simulium ochraceum vectors (one-sided 95% confidence interval [CI], 0-0.086%), and no IgG4 antibody positives to recombinant antigen OV16 were found in a sample of 3,232 school children (95% CI, 0-0.009%). We also found no evidence of microfilariae in the anterior segment of the eye in 363 area residents (95% CI, 0-0.08%). Our interpretation of these data, together with historical information, suggest that transmission of O. volvulus is permanently interrupted in Santa Rosa and that ivermectin treatments there can be halted.


Sujet(s)
Vecteurs insectes/parasitologie , Onchocerca volvulus/isolement et purification , Onchocercose/transmission , Simuliidae/parasitologie , Animaux , Enfant , Maladies endémiques , Test ELISA , Femelle , Guatemala/épidémiologie , Humains , Immunoglobuline G/sang , Mâle , Onchocercose/épidémiologie , Onchocercose/parasitologie , Onchocercose/prévention et contrôle , Études séroépidémiologiques
18.
J Med Entomol ; 43(4): 701-6, 2006 Jul.
Article de Anglais | MEDLINE | ID: mdl-16892627

RÉSUMÉ

Onchocerciasis is a serious disease vectored by black flies in the genus Simulium that are infected with the filarial parasite Onchocerca volvulus. In the Americas, black flies of the Simulium ochraceum s.l. species complex are important vectors of this parasite. Cytological studies have suggested that this species complex consists of at least three cytotypes that inhabit distinct habitats. In this study, the NADH dehydrogenase subunit four (ND4) and internal transcribed spacer (ITS) of the ribosomal RNA gene cluster were used to explore the degree of genetic diversity among S. ochraceum s.l. populations found in the three O. volvulus foci in Mexico. Both sequence regions were found to exhibit intra- and interpopulation variation. Four different ND4 alleles were found among the populations examined. Similarly, variation was noted in the ITS domain sequences within and among populations. Variation within the ITS sequence was primarily confined to a complex microsatellite locus. Four ITS length variants were observed, two of which were only seen in flies collected from the onchocerciasis focus in northern Chiapas. These data suggest that the ND4 and ITS sequences may prove to be useful markers for exploring interactions within and among the S. ochraceum s.l. populations in Mexico.


Sujet(s)
Espaceur de l'ADN ribosomique/génétique , Gènes de mitochondrie/génétique , Variation génétique , Vecteurs insectes/génétique , NADH dehydrogenase/génétique , Simuliidae/génétique , Animaux , Séquence nucléotidique/génétique , Amorces ADN/composition chimique , Femelle , Fréquence d'allèle/génétique , Gènes d'insecte/génétique , Géographie , Haplotypes/génétique , Analyse d'hétéroduplex , Vecteurs insectes/enzymologie , Mexique , Répétitions microsatellites/génétique , Onchocercose/transmission , Réaction de polymérisation en chaîne , Simuliidae/enzymologie
19.
Am J Trop Med Hyg ; 74(6): 1026-33, 2006 Jun.
Article de Anglais | MEDLINE | ID: mdl-16760515

RÉSUMÉ

To study the impact of mass Mectizan treatment on Onchocerca volvulus transmission in Mexico, entomological surveys were carried out in the endemic foci of Oaxaca, Southern Chiapas, and Northern Chiapas. Collected flies were screened by polymerase chain reaction (PCR) for O. volvulus parasites. The prevalence of infected and infective flies was estimated using the PoolScreen algorithm and with a novel probability-based method. O. volvulus infective larvae were not detected in flies from 6/13 communities. In 7/13 communities, infective flies were detected, with prevalences ranging from 1.6/10,000 to 29.0/10,000 and seasonal transmission potentials ranging from 0.4 to 3.3. Infected and infective flies were found in a community in Northern Chiapas, suggesting that, according to World Health Organization criteria, autochthonous transmission exists in this focus. These data suggest that O. volvulus transmission in Mexico has been suppressed or brought to a level that may be insufficient to sustain the parasite population.


Sujet(s)
Vecteurs insectes/parasitologie , Insecticides , Ivermectine , Onchocerca volvulus , Onchocercose/épidémiologie , Simuliidae/parasitologie , Algorithmes , Animaux , Amorces ADN/composition chimique , Maladies endémiques/prévention et contrôle , Programmes gouvernementaux/normes , Mexique/épidémiologie , Onchocerca volvulus/génétique , Onchocerca volvulus/isolement et purification , Onchocercose/prévention et contrôle , Onchocercose/transmission , Réaction de polymérisation en chaîne/méthodes , Prévalence , Saisons , Facteurs temps
20.
Infect Genet Evol ; 6(3): 171-6, 2006 May.
Article de Anglais | MEDLINE | ID: mdl-15919244

RÉSUMÉ

DNA from Onchocerca volvulus from Oaxaca and Chiapas, Mexico were used as templates to amplify members of the O-150 Onchocerca specific repeat sequence family. The resulting PCR amplicons all hybridized with OVS2, an oligonucleotide that has been previously shown to recognize amplicons derived from O. volvulus with 100% sensitivity. However, when PCR products amplified from the O. volvulus specific plasmid pOVS134 were used as a probe, most samples did not hybridize. Similarly, when PCR products amplified from DNA isolated from adult O. volvulus from Oaxaca were used as a probe, amplicons from adult worms from both Oaxaca and Chiapas were recognized, but PCR products from infected black flies from Chiapas were not recognized. Amplicons derived from an adult worm from Chiapas hybridized with PCR products produced from adult parasites from both Oaxaca and Chiapas and to PCR products derived from the DNA of infected black flies from Chiapas. These data, when taken together, suggest that differences exist among the repeat sequence populations of parasites from Oaxaca and Chiapas in Mexico, suggesting that the O-150 repeat sequence family may be a useful tool for biogeographic studies of O. volvulus in the Americas.


Sujet(s)
ADN des helminthes/métabolisme , Onchocerca volvulus/génétique , Onchocerca volvulus/isolement et purification , Animaux , Technique de Southern , Sondes d'ADN , ADN des helminthes/composition chimique , Amplification de gène , Gènes d'helminthe , Variation génétique , Géographie , Vecteurs insectes/génétique , Vecteurs insectes/parasitologie , Larve/génétique , Mexique , Hybridation d'acides nucléiques , Onchocerca volvulus/croissance et développement , Plasmides/génétique , Réaction de polymérisation en chaîne , Séquences répétées d'acides nucléiques , Simuliidae/génétique , Simuliidae/parasitologie , Matrices (génétique)
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE